AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.200
+0.010 (0.84%)
At close: Dec 12, 2025, 4:00 PM EST
1.210
+0.010 (0.83%)
After-hours: Dec 12, 2025, 7:44 PM EST
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $32.88 million as of December 12, 2025. Its market cap has decreased by -20.83% in one year.
Market Cap
32.88M
Enterprise Value
-29.04M
1-Year Change
-20.83%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $32.88M, a decrease of -88.30%. That is a compound annual growth rate of -43.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 32.88M | -20.25% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |